Additionally, lifestyle interventions such as regular physical activity of minimum 150 min per week and pharmacological approaches as discussed in this review could further alleviate TMAO-related complications
Impact of GLP-1 receptor agonists on blood pressure, heart rate and hypertension among patients with type 2 diabetes: A systematic review and network meta-analysis
(2010) proved this in a rat MCL transection model
Retatrutide: Phase-2 trial Retatrutide is an investigational triple agonist (GLP-1, GIP and glucagon receptors), adding a third hormone target to potentially boost metabolism further
It also suppresses matrix metalloproteinase-3 (MMP-3) expression in stressed neurons, indirectly deactivating microglia
While determinations are made individually, suitable candidates typically have a Body Mass Index (BMI) of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition